Over 6 months, the researcher loses $234 to degradation, enough to buy more than 1.5 additional vials
A phase 3 trial of tebentafusp was the first to show reduced risk of death from metastatic uveal melanoma compared to investigators choice (dacarbazine, pembrolizumab, or ipilimumab) in treatment-naive HLAA*02:01-positive patients with metastatic uveal melanoma
deAssis PMCastroLSSiqueiraAFDelgadoJde CHamiltonTRGoissisMDet al
CareBareRX coordinates the process but does not control the medical decision and does not dispense medication
Oral GLP-1 therapy is used to manage type 2 diabetes and support weight loss by regulating blood sugar and appetite
It describes them as customized by licensed pharmacists working under provider orders, and says they require the same medical oversight, baseline labs and follow-up care as branded options